The global arthritis market encompasses a spectrum of pharmaceuticals, therapies, and interventions to mitigate the impact of arthritis, a prevalent musculoskeletal condition characterized by joint inflammation. Pharmaceutical offerings include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologics designed to manage symptoms and slow disease progression. Physiotherapy and lifestyle modifications also play crucial roles in holistic arthritis management.
Data Bridge Market Research analyses that the Global Arthritis Market, which was USD 4.3 billion in 2022, is expected to reach USD 8.63 billion by 2030 and undergo a CAGR of 9.10% from 2023 to 2030.
"Increasing prevalence of arthritis drives the market growth"
The increasing prevalence of various forms of arthritis, such as rheumatoid arthritis, osteoarthritis, and psoriatic arthritis, is a substantial driver for the arthritis market. As these conditions become more prevalent globally, there is a heightened demand for effective treatments and interventions. Consequently, the market experiences growth as healthcare systems strive to meet the rising needs of patients grappling with arthritis-related symptoms and complications.
What restraints the growth of the global arthritis market?
"High treatment costs hamper the market growth"
High treatment costs pose a substantial obstacle in the arthritis market, creating a barrier for patients seeking effective management. The prolonged nature of arthritis care, involving extended periods of medication, physical therapy, and potential surgical interventions, contributes to the financial burden on individuals and healthcare systems. This economic challenge deters patients from pursuing comprehensive and sustained treatment plans, impacting market growth as accessibility and affordability become critical factors in adopting arthritis management strategies.
Segmentation: Global Arthritis Market
The global arthritis market is segmented on the basis of rheumatoid drug type, rheumatoid treatment, rheumatoid diagnosis, osteoarthritis type, osteoarthritis treatment, osteoarthritis diagnosis, route of administration, end user, and distribution channel.
- On the basis rheumatoid drug type, the global arthritis market is segmented into biologics, non-biologics, steroids, analgesics, glucocorticoids, and others
- On the basis rheumatoid treatment, the global arthritis market is segmented into synovectomy, tendon repair, joint fusion, symptomatic treatment, intermediate corticosteroid therapies, and DMARD therapies
- On the basis rheumatoid diagnosis, the global arthritis market is segmented into C.R.P. test, C.C.P., and E.S.R. test
- On the basis osteoarthritis type, the global arthritis market is segmented into hip, spinal, knee, foot and ankle, shoulder, and hand
- On the basis osteoarthritis treatment, the global arthritis market is segmented into medication, drugs, assistive devices, surgery, and therapy
- On the basis osteoarthritis diagnosis, the global arthritis market is segmented into imaging, joint fluid analysis, and others
- On the basis route of administration, the global arthritis market is segmented into oral, and parenteral
- On the basis end user, the global arthritis market is segmented into hospitals, clinics, household, medical institutes, research organizations, and others
- On the basis distribution channel, the global arthritis market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and drug stores
Regional Insights: North America dominates the Global Arthritis Market
North America dominates the global arthritis market, driven by major key players, robust healthcare infrastructure, and substantial disposable income. The region's high healthcare expenditure reflects a commitment to advanced arthritis treatments. The convergence of these factors positions North America as a key contributor to the market's growth, leading in research, innovation, and the adoption of cutting-edge arthritis management strategies.
Asia-Pacific is expected to dominate the global arthritis market from 2023 to 2030. This growth is fueled by increasing research and development activities, rising investments in the healthcare sector, and growing government support. The region's proactive initiatives contribute to the advancement of arthritis treatment options, positioning Asia-Pacific as a key player in shaping the trajectory of the global arthritis market.
Recent Developments: Global Arthritis Market
- In December 2022, Merck KGaA revealed a research collaboration and commercial license agreement with Mersana Therapeutics. The partnership aims to discover novel antibody-drug conjugates (A.D.C.s) utilizing Mersana's proprietary Immunosynthen STING-agonist A.D.C. platform, targeting up to two specified targets
- In February 2023, Roche expanded collaboration with Janssen Biotech to develop companion diagnostics for targeted therapies, reinforcing efforts in research and innovation. This collaboration enhances both companies' capabilities in advancing precision medicine and personalized treatment approaches
To know more about the study, visit https://www.databridgemarketresearch.com/reports/global-arthritis-market
The Prominent Key Players Operating in the Global Arthritis Market Include:
- Johnson & Johnson Private Limited(U.S.)
- AbbVie Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Amgen Inc. (U.S.)
- Bristol-Myers Squibb Company(U.S.)
- F. Hoffmann-La Roche Ltd.(U.S.)
- UCB S.A.(Belgium)
- Gilead Sciences, Inc. (U.S.)
- Boehringer Ingelheim International GmbH.(Germany)
- Lilly(U.S.)
- Sanofi (France)
- Novartis AG (Switzerland)
- AstraZeneca(U.S.)
- Astellas Pharma Inc.(Japan)
- Galapagos NV (Belgium)
- Taisho Pharmaceutical Holdings Co., Ltd.(U.K.)
- Regeneron Pharmaceuticals Inc.(U.S.)
- Swedish Orphan Biovitrum AB (publ) (Sweden)
- ABIOGEN PHARMA S.p.A (Italy)
- Kolon TissueGene, Inc.(U.S.)
- Ampio Pharmaceuticals Inc. .(U.S.)
- Merck Sharp & Dohme Corp. .(U.S.),
- GlaxoSmithKline plc (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of global arthritis market companies, contact: https://www.databridgemarketresearch.com/contact
Research Methodology: Global Arthritis Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
